A 10-week Randomized, Double-blind, Placebo-controlled, Prospective, International, Multicentre, Phase IIa Study of S42909 on Leg Ulcer Healing.
Latest Information Update: 05 Nov 2021
Price :
$35 *
At a glance
- Drugs S 42909 (Primary)
- Indications Leg ulcer; Varicose ulcer
- Focus Proof of concept; Therapeutic Use
- Sponsors ILKOS THERAPEUTICS
- 16 Feb 2020 This trial has been completed in Slovakia, according to European Clinical Trials Database.
- 13 Feb 2020 Status changed from active, no longer recruiting to completed.
- 03 Dec 2019 Status changed from recruiting to active, no longer recruiting.